Latest Breaking News On - கார்ல் நல்ல ஆண்டு - Page 1 : vimarsana.com

Search jobs UofG Announces Research Collaboration with Lilly to Discover Potential New Drug Targets The University of Glasgow has entered into a research collaboration with pharmaceutical company Eli Lilly and Company, that aims to discover and validate the next generation of drug targets for immunological diseases. The £4.6million research collaboration, due to last four years, will work across four diseases – psoriatic arthritis, rheumatoid arthritis, fibrosis and vasculitis – and will be led by the University of Glasgow’s Institute of Infection, Immunity and Inflammation. The collaboration will allow scientists from UofG and Lilly to work together in order to drive the research forward – a move researchers hope will help enable the identification of first-in-class therapeutics for people suffering with these devastating and costly conditions. For instance, rheumatoid arthritis alone affects 0.3-1% of people across the globe and it is estimate

Glasgow cityUnited kingdomAnton muscatelliNeil basuEli lillyIain mcinnesAjay nirulaThomas ottoCarl goodyearMariola kurowska stolarskaStefan siebertNeal millarPrincipal of the universityVeterinary life sciencesUniversity of glasgowUniversity of glasgow institute infection